Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04607954
Title Durvalumab and Topotecan for the Treatment of Relapsed or Refractory Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Mayo Clinic
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Mayo Clinic in Rochester RECRUITING Rochester Minnesota 55905 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field